Guardians keep José Ramírez out of starting lineup versus Mets as left-wrist inflammation lingers

CLEVELAND, Aug. 4, 2026 - José Ramírez’s return from left hamate surgery has been managed with caution, and the next step in that plan came on Tuesday. The Guardians did not include the 33-year-old third baseman in the starting lineup for the opener against the New York Mets, citing left-wrist inflammation.

Ramírez’s timeline has been shaped by the type of hand and wrist injury that can affect batting grip, bat speed, and swing finish. After he returned last month, manager Stephen Vogt indicated the club would be thoughtful about how much Ramírez plays and when, reflecting a balance between getting him back to game action and limiting stress on the healing area.

The decision to sit him for the opener is consistent with that posture. It also underscores how the Guardians are treating his workload in a short-term, game-to-game way rather than assuming a straight line back to full availability. For Cleveland, those incremental choices can matter just as much as the original rehabilitation milestone, because wrist inflammation can flare even when a player is otherwise cleared.

The matchup itself adds context. Facing the Mets early in the series, Cleveland chose to start without Ramírez’s bat in the lineup, a notable shift for a lineup that typically relies on his presence in the middle of the order. His absence changes the distribution of at-bats and can force the club to adjust its protection and run-production look against a New York staff.

While the organization has not suggested that the situation is anything other than a health management issue, the wording from the club is clear that the reason for sitting Ramírez in this game is inflammation in his left wrist. That distinction matters, because it frames Tuesday’s move less as a performance-related benching and more as a precaution tied to the physical recovery process.

For fans, the most practical question becomes what the Guardians do next with his availability. In these situations, the club’s next lineup decisions will likely be monitored closely for patterns, such as whether Ramírez returns immediately after a rest day or continues to see targeted restrictions based on how the wrist responds.

The Mets series is an important stretch for both teams, and Cleveland’s planning around Ramírez illustrates how roster construction can be influenced by medical considerations. The Guardians will continue to weigh the long-term upside of Ramírez’s role against the short-term cost of aggravating inflammation during games.

If Ramírez is available in subsequent contests, the first indicator will be whether the club returns him to a full starting assignment or uses a partial role first. Either way, Tuesday’s lineup choice provides a clear snapshot of how the Guardians are approaching the final phase of reintegration after surgery: measured, responsive, and centered on maintaining the player’s ability to stay in the lineup without setbacks.